Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that ...

CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...

Cells are regularly faced with environmental stresses that may damage or destroy them. To survive, they quickly adjust their ...

Discover how precision biotherapeutics can transform healthcare in India by personalizing treatments based on genetic and ...

Cells are regularly faced with environmental stresses that may damage or destroy them. To survive, they quickly adjust their gene expression to protect themselves.

Researchers have mapped the regulatory elements that control the FOXP3 gene, which is implicated in maintaining balance in ...

At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...

After a rich political harvest in Bihar, Prime Minister Narendra Modi will be in Coimbatore on Nov 19 to inaugurate the South ...